Why study doxycycline for schizophrenia prevention in at‑risk youth?

There has been a rise in people that cut gluten out of their diet to address gut symptoms, despite not having a diagnosis of coeliac disease. 

New research is shedding light on what might actually be at play in non-coeliac gluten sensitivity. 

Also, how a common antibiotic might lower the risk of developing schizophrenia when given to young people at risk. 

And a look at the cancer prevention strategies that could have a big impact, but that most countries aren't taking on board. 

References

• Government expenditure on public health activities in Australia 2023–24 - AIHW
• Global prevalence of hypertension among children and adolescents aged 19 years or younger: an updated systematic review and meta-analysis
• Non-coeliac gluten sensitivity - the Lancet
• Global prevalence of self-reported non-coeliac gluten and wheat sensitivity: a systematic review and metaanalysis
• Doxycycline Use in Adolescent Psychiatric Patients and Risk of Schizophrenia: An Emulated Target Trial
• Cancers attributable to alcohol - IARC
• Alcohol: a major preventable cause of cancer (IARC Evidence Summary Brief No. 6)